Date post: | 02-Jul-2015 |
Category: |
Healthcare |
Upload: | ohdsi |
View: | 124 times |
Download: | 2 times |
Evidence-Enhanced Product Labeling
(EPLs)
Jon DukeApril 15, 2014
What Are We Trying to Solve?
A Problem with Labeling
• While considered the official source of drug safety information
– Labels are infrequently read by patient or providers
– The evidence for a given ADR is often scant
– They are one-size-fits-all and do not support personalized decision-making
What Are We Trying to Solve?
A Problem with OHDSI
• While we are developing superb methods and brilliant tools to convey evidence on drug safety– Driving use of external tools requires significant
activation energy
– Awareness of the evidence being generated by OHDSI may diffuse slowly even to those who would be extremely interested (e.g., drug knowledge vendors)
– Users will generally need to know what they are looking for (e.g., what drug-outcome pairs)
The EPL Big Picture
4
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
~~~ ~~ ~~ ~~
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
StructuredProduct Label
EnhancedProduct Label
Evidence-Enhanced Product Labeling
• EPL is a platform for injecting approved product labeling with evidence from external sources
• Evidence may manifest as
– visual emphasis / de-emphasis of label content
– on-demand display of data and visualizations
• EPL is a trojan horse for getting people to see the incredible work of OHDSI while using a standard reference
Enhanced Product Labeling:Framework vs App
• EPL is fundamentally a framework that can work with any web application
• Two Reference Apps
– Embedding of HOMER-like content within SPL (DOI_HOI evidence base)
– Embedding of PLATO-like content within SPL (requires mechanism to capture patient data-manual inputs, CCD, blue button, etc)
JSLibrary
OHDSIAPIs
Other Evidence Sources
OHDSIKB
OHDSIPLATO
Services
SPL
Potential OHDSI KB Content
What’s in an SPL?Part 1: XML (the content)
9
XML/XSL/CSS HTML
What’s in an SPL?Part 2: XSLT (the format)
10
What’s in an SPL?Part 3: CSS (the style)
11
What’s in an SPL?Roll them together HTML
12
What’s in an SPL?HTML
13
What’s in an SPL?HTML
14
EPL Javascript
SPLXML/XSL/CSS HTML
EPL / OHDSIAPIs
Other Evidence Sources
OHDSIKB
OHDSIPLATO
Services
Web App
EPL.js
Structured Product
Label
~~~ ~~ ~~ ~~ ~~
~~ ~~ ~~ ~~~ ~~
~ ~~ ~~~ ~~ ~~~
~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~
Tell me all the known ADRs for this drug
From SPL to EPL
EPL / OHDSIAPIs
EPL / OHDSIAPIs
Web App
EPL.js
Structured Product
Label
~~~ ~~ ~~ ~~ ~~
~~ ~~ ~~ ~~~ ~~
~ ~~ ~~~ ~~ ~~~
~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~
From SPL to EPL
Web App
EPL.js
From SPL to EPL
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
Web App
EPL.js
From SPL to EPL
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
Web App
EPL.js
From SPL to EPL
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
Web App
EPL.js
From SPL to EPL
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
Web App
EPL.js
Tell me the specific evidence for this HOIDOI_HOI_id=234515
Detail On-Demand
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~
~~ ~~ ~~~
EPL / OHDSIAPIs
EPL / OHDSIAPIs
Web App
EPL.js
Structured Product
Label
~~~ ~~ ~~ ~~ ~~
~~ ~~ ~~ ~~~ ~~
~ ~~ ~~~ ~~ ~~~
~~ ~~ ~~
~~~ ~~ ~~ ~~ ~~
~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~
From SPL to EPL
Adverse Reactions
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ns
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~
~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~
~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~
~~~ ~~ ~~ ~~Advanced Jquery Tooltips supportAJAX calls, visualzations, full HTML5
Example EPL Prototype
25
Example EPL Prototype
26
Final Thoughts
• Evidence-enhancement not limited to SPLs, could be applied to SPCs or any other web content with identifiable drugs and outcomes
• Designed to be flexible in terms of novel evidence sources and presentation layers
• Will develop in parallel with OHDSI KB and APIs
27
Thanks!
Questions?
28